
GCC Heart Failure Treatment Devices Market Research Report: Forecast (2025-2030)
GCC Heart Failure Treatment Devices Market - By Product Type (Implantable Cardioverter-Defibrillator {ICD}, Cardiac Resynchronization Therapy {CRT} [Cardiac Resynchronization Thera...py Pacemaker {CRT- P}, Cardiac Resynchronization Therapy Defibrillator {CRT- D}], Others), By End User (Hospitals, Ambulatory Surgical Centers, Specialty Clinics) and Others Read more
- Healthcare
- Feb 2025
- 160
- PDF, Excel, PPT
Market Definition
Heart Failure Treatment Devices including Implantable cardioverter defibrillators (ICD), Cardiac resynchronization therapy (CRT), and others are medical devices for treating and managing patients with advanced heart failure.
Market Insights & Analysis: GCC Heart Failure Treatment Devices Market (2025-30):
The GCC Heart Failure Treatment Devices Market size was valued at around USD 765 million in 2024 and is projected to reach USD 986 million by 2030. Along with this, the market is estimated to grow at a CAGR of around 4.22% during the forecast period, i.e., 2025-30. With GCC countries like the UAE, Saudi Arabia, Oman, Kuwait, etc., having a significant number of patients with diabetes, the cases of heart failure with reduced ejection fraction have been rapidly increasing. This happens as high blood sugar tends to harm the blood vessels & the nerves controlling one’s heart over time. Eventually, the need for heart failure treatment devices like ICD & CRT has been increasing in the region, thereby boosting the overall GCC Heart Failure Treatment Devices Market. For instance,
- As the International Diabetes Federation (IDF) mentioned, in 2021 there were about 4,274,100 patients with diabetes. The cases are expected to reach 5,631,000 by 2030.
Report Coverage | Details |
---|---|
Historical Years | 2020-23 |
Base Years
|
2024
|
Forecast Years
|
2025-30
|
Market Value in 2024 | USD 765 Million |
Market Value in 2030 | USD 986 Million |
CAGR (2025-30) | 4.22% |
Leading Country | UAE |
Top Key Players | Medtronic, Abbott, Boston Scientific Corporation, Biotronik, Johnson & Johnson Services, Inc. (Abiomed), and others |
Key Report Highlights |
|
*Boost strategic growth with in-depth market analysis - Get a free sample preview today!
Further, hypertension rates have been high in countries like the UAE, Saudi Arabia, Qatar, Oman, etc. This has been due to the low levels of physical activity, limited consumption of fruits & vegetables, high-fat diet, smoking, etc. witnessed among the regional population. High blood pressure weakens the heart, thickens the blood vessel walls, and contributes to increasing the heart’s workload. The patient in due course suffers from heart failure. A similar scenario has been there in the GCC region where a significant number of patients have been developing hypertension and eventually heart failure. Therefore, the demand for heart failure treatment devices like ICD, CRT, and others has been continuously there in the region.
Moreover, there has been a heightened prevalence of obesity in GCC countries with rates increasing tremendously due to extreme levels of wealth in countries like the UAE & Qatar which allows them to spend more on unhealthy foods. In addition, extreme temperatures crossing the 50 degrees Celsius threshold in countries like the UAE, Saudi Arabia, & Kuwait among others have been discouraging individuals from taking part in strenuous physical activity outside. This high level of obesity has been greatly causing hospital admissions due to heart failure in the region, subsequently raising the demand for heart failure treatment technologies like ICD & CRT. For instance, as stated by the World Health Organization (WHO), in GCC countries, obesity prevalence in GCC countries like Kuwait, Qatar, and Saudi Arabia has been 38%, 35%, and 35% respectively.

GCC Heart Failure Treatment Devices Market Driver:
Alarming Heart Failure Rates in the Region – Although, infectious diseases like COVID-19 and tuberculosis have done immense harm to the global population including to those individuals based in the UAE, Saudi Arabia, and other GCC countries. However, over the years, non-communicable diseases (NCDs) like cardiovascular diseases and heart failure that at one time were majorly heard in Western nations like the US & Europe have been greatly impacting the health status of the GCC nations.
The overall prevalence of these diseases particularly heart failure in the UAE, Qatar, Saudi Arabia, and others has been at the top. This has been connected primarily to the incidence & prevalence of risk factors such as diabetes, obesity, smoking, sedentary lifestyle, increased consumption of fatty foods, etc. These have been responsible for causing coronary artery disease (CAD) and eventually heart failure. Moreover, these have been at the topmost for causing a significant number of deaths. Thereby, the need for heart failure devices like ICD, CRT, impella, & LVAD has been high to help patients survive heart failure & reduce mortality rates. In the coming years, the heart failure treatment device market will also be registering significant growth in the GCC region.
GCC Heart Failure Treatment Devices Market Challenge:
Import Dependency Giving Rise to Medical Inflation & Supply Chain Challenges – GCC nations like the UAE & Saudi Arabia have been extremely dependent upon imported medical devices for heart failure treatment. Local manufacturing in these nations has been limited to producing basic items like PPE, syringes, and administration devices. Although importing medical devices has been crucial for these countries to fulfill their healthcare needs, it has created certain challenges for the overall Heart Failure Treatment Devices Market in the GCC region. The rising cost of healthcare services has been one of the major challenges arising from the import of medical devices. This has been restricting healthcare facilities with limited budgets from procuring advanced devices like ICD & CRT-D and offering treatments for heart failure. Moreover, the hospitals that do procure these devices tend to offer services at high cost making it difficult for patients to receive treatment in their home country. Eventually, the demand for these devices declines.
Additionally, high reliance on imports has exposed the region to supply chain disruptions like that occurred during the recent pandemic-imposed lockdowns. These not only cause delays in delivery processes & patient care but also affect the company’s businesses & revenue. Hence, the GCC Heart Failure Treatment Devices Market has been facing restrictions in complete expansion due to the aforementioned factors.
GCC Heart Failure Treatment Devices Market Trend:
Development of AI Integrated & Miniaturized Devices – In recent years, AI has gained immense traction in healthcare. In the case of heart failure treatment technologies like ICD, CRT-P, & CRT-D, AI integration has been benefitting patients greatly. This is by improving the response rates and reducing the hospital readmission rates which have been high due to heart failure in GCC countries like the UAE, Saudi Arabia, and others. As a result demand & acceptance for such AI-integrated ICDs & CRTs have been increasing in the region, propelling the overall GCC Heart Failure Treatment Devices Market.
Further, in recent years the focus has been on improving patient comfort and this has led to the development of miniaturized devices. These devices without compromising on quality, tend to be more advanced, minimally invasive, reduce risk post-surgery, and offer the benefit of shorter hospital stays. The healthcare professionals and patients thereby have been inclining more towards such devices like AUTOGENᵀᴹ MINI ICD & DYNAGENᵀᴹ MINI ICD by Boston Scientific Corporation which are 20% smaller and 24% thinner than most marketed ICDs. As more companies start bending towards offering such kind of AI-integrated and miniaturized heart failure treatment devices, they are expected to register immense growth.
GCC Heart Failure Treatment Devices Market (2025-30): Segmentation Analysis
GCC Heart Failure Treatment Devices Market study of MarkNtel Advisors evaluates & highlights the major trends and influencing factors in each segment. It includes predictions for 2025–2030 at the regional level. Based on the analysis, the market has been further classified as:
Based on Product Type:
- Implantable Cardioverter-Defibrillator (ICD)
- Cardiac Resynchronization Therapy (CRT)
- Cardiac Resynchronization Therapy Pacemaker (CRT- P)
- Cardiac Resynchronization Therapy Defibrillator (CRT- D)
- Others
Cardiac Resynchronization Therapy (CRT) devices are expected to hold a significant market share of the overall GCC Heart Failure Treatment Devices Market. This has been because, a heightened proportion of patients in regional countries like Bahrain, the UAE, Kuwait, and others have been witnessing heart failure symptoms such as shortness of breath, fatigue, and exercise intolerance. To carry on their day-to-day activities without many restrictions, reduce the severity of the disease, and improve life expectancy, these patients have been undergoing CRT implantation surgeries. Consequently, the segmental market size has been expanding.
Further, GCC countries like the UAE & Saudi Arabia thoroughly follow international guidelines such as those set by the American Heart Association & European Society of Cardiology. These international guidelines highly advocate the usage of CRT devices for patients with heart failure and thereby healthcare providers in the GCC countries have been accordingly indicating these devices to the patients in need. Eventually, the demand for CRT devices has been increasing in the region.
Based on End User:
- Hospitals
- Specialty Clinics
- Ambulatory Surgical Centers
Among all the different types of end-users, the largest market share has been held by the hospitals. Hospitals are primary healthcare facilities for patients with heart failure and other cardiac conditions in the GCC region and thereby generate more demand for devices like ICD, CRT, heart pumps, and others. Further, in GCC nations, hospitals tend to hire world-class board-certified cardiac surgeons & specialists. Along with having vast experience in implantation and transplantation surgeries, these professionals know international guidelines and procedures and offer care accordingly. This fosters trust among the patients who then receive treatment in these hospitals, thereby driving the segment’s market size.
Moreover, countries like Bahrain, Kuwait, and others have been actively investing in the construction of new cardiac hospitals as well as the expansion of existing ones as the patient population is increasing. Also, the countries are expecting medical tourists from across the Gulf, and newer hospitals would be required to cater to them. Eventually, the opportunistic demand for heart failure treatment technologies would arise from the hospitals.

GCC Heart Failure Treatment Devices Market (2025-30): Regional Projections
Geographically, the GCC Heart Failure Treatment Devices Market expands across:
- Saudi Arabia
- The UAE
- Qatar
- Oman
- Kuwait
- Bahrain
The UAE holds a significant market share of the GCC Heart Failure Treatment Devices Market. This has been due to the alarming rates of heart failure, arrhythmia, and other cardiac conditions in the country where ICD & CRT implantation becomes necessary to safeguard the patient’s life. Further, a large number of patients both men & women in the country have been developing the issue of high blood pressure as a result of their sedentary lifestyle and high levels of obesity. Hypertension being a major causative factor has been contributing to the escalated number of hospital admissions due to heart failure in the country. The demand for heart failure treatment devices thereby has been surging in the UAE.
Moreover, the demand for impella heart pumps and LVADs has seen a significant boost in the UAE. This is because of the limited number of donors in the country and to save the patient’s life for the period until they receive a heart transplant, the device implantation has become necessary.
Gain a Competitive Edge with Our GCC Heart Failure Treatment Devices Market Report
- GCC Heart Failure Treatment Devices Market by MarkNtel Advisors provides a detailed & thorough analysis of market size & share, growth rate, competitive landscape, and key players. This comprehensive analysis helps businesses gain a holistic understanding of the market dynamics & make informed decisions.
- This report also highlights current market trends & future projections, allowing businesses to identify emerging opportunities & potential challenges. By understanding market forecasts, companies can align their strategies & stay ahead of the competition.
- GCC Heart Failure Treatment Devices Market Report aids in assessing & mitigating risks associated with entering or operating in the market. By understanding market dynamics, regulatory frameworks, and potential challenges, businesses can develop strategies to minimize risks & optimize their operations.
*Reports Delivery Format - Market research studies from MarkNtel Advisors are offered in PDF, Excel and PowerPoint formats. Within 24 hours of the payment being successfully received, the report will be sent to your email address.
Frequently Asked Questions
- Market Segmentation
- Introduction
- Market Definition
- Research Process
- Assumption
- Executive Summary
- GCC Heart Failure Treatment Devices Market Trends & Insights
- GCC Heart Failure Treatment Devices Market Dynamics
- Growth Drivers
- Challenges
- GCC Heart Failure Treatment Devices Market Hotspot & Opportunities
- GCC Heart Failure Treatment Devices Market Supply Chain Analysis
- GCC Heart Failure Treatment Devices Market Regulation & Policy
- GCC Heart Failure Treatment Devices Market Outlook, 2020-2030F
- Market Size & Analysis
- By Revenues (USD Million)
- Market Share & Analysis
- By Product Type
- Implantable Cardioverter-Defibrillator (ICD)
-Market Size & Forecast 2020-2030, USD Million - Cardiac Resynchronization Therapy (CRT)- Market Size & Forecast 2020-2030, USD Million
- Cardiac Resynchronization Therapy Pacemaker (CRT- P)- Market Size & Forecast 2020-2030, USD Million
- Cardiac Resynchronization Therapy Defibrillator (CRT- D)- Market Size & Forecast 2020-2030, USD Million
- Others (Heart Pumps, LVAD, etc.)- Market Size & Forecast 2020-2030, USD Million
- Implantable Cardioverter-Defibrillator (ICD)
- By End User
- Hospitals - Market Size & Forecast 2020-2030F, USD Million
- Ambulatory Surgical Centers- Market Size & Forecast 2020-2030F, USD Million
- Specialty Clinics- Market Size & Forecast 2020-2030F, USD Million
- By Country
- Saudi Arabia
- The UAE
- Qatar
- Oman
- Kuwait
- Bahrain
- By Competitors
- Competition Characteristics
- Market Share & Analysis
- By Product Type
- Market Size & Analysis
- Saudi Arabia Heart Failure Treatment Devices Market Outlook, 2020-2030F
- Market Size & Analysis
- By Revenues (USD Million)
- Market Share & Analysis
- By Product Type - Market Size & Forecast 2020-2030F, USD Million
- By End User - Market Size & Forecast 2020-2030F, USD Million
- Market Size & Analysis
- The UAE Heart Failure Treatment Devices Market Outlook, 2020-2030F
- Market Size & Analysis
- By Revenues (USD Million)
- Market Share & Analysis
- By Product Type - Market Size & Forecast 2020-2030F, USD Million
- By End User - Market Size & Forecast 2020-2030F, USD Million
- Market Size & Analysis
- Qatar Heart Failure Treatment Devices Market Outlook, 2020-2030F
- Market Size & Analysis
- By Revenues (USD Million)
- Market Share & Analysis
- By Product Type - Market Size & Forecast 2020-2030F, USD Million
- By End User - Market Size & Forecast 2020-2030F, USD Million
- Market Size & Analysis
- Oman Heart Failure Treatment Devices Market Outlook, 2020-2030F
- Market Size & Analysis
- By Revenues (USD Million)
- Market Share & Analysis
- By Product Type - Market Size & Forecast 2020-2030F, USD Million
- By End User - Market Size & Forecast 2020-2030F, USD Million
- Market Size & Analysis
- Kuwait Heart Failure Treatment Devices Market Outlook, 2020-2030F
- Market Size & Analysis
- By Revenues (USD Million)
- Market Share & Analysis
- By Product Type - Market Size & Forecast 2020-2030F, USD Million
- By End User - Market Size & Forecast 2020-2030F, USD Million
- Market Size & Analysis
- Bahrain Heart Failure Treatment Devices Market Outlook, 2020-2030F
- Market Size & Analysis
- By Revenues (USD Million)
- Market Share & Analysis
- By Product Type - Market Size & Forecast 2020-2030F, USD Million
- By End User - Market Size & Forecast 2020-2030F, USD Million
- Market Size & Analysis
- GCC Heart Failure Treatment Devices Market Key Strategic Imperatives for Success & Growth
- Competition Outlook
- Company Profile
- Medtronic
- Business Description
- Product Portfolio
- Strategic Alliances or Partnerships
- Recent Developments
- Financial Details
- Others
- Abbott
- Business Description
- Product Portfolio
- Strategic Alliances or Partnerships
- Recent Developments
- Financial Details
- Others
- Boston Scientific Corporation
- Business Description
- Product Portfolio
- Strategic Alliances or Partnerships
- Recent Developments
- Financial Details
- Others
- Biotronik
- Business Description
- Product Portfolio
- Strategic Alliances or Partnerships
- Recent Developments
- Financial Details
- Others
- Johnson & Johnson Services, Inc. (Abiomed)
- Business Description
- Product Portfolio
- Strategic Alliances or Partnerships
- Recent Developments
- Financial Details
- Others
- Others
- Medtronic
- Company Profile
- Disclaimer
